Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 254

1.

Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes.

Wadwa RP, Laffel LM, Shah VN, Garg SK.

Diabetes Technol Ther. 2018 Jun 14. doi: 10.1089/dia.2018.0150. [Epub ahead of print]

PMID:
29901421
2.

Transitions in Care from Pediatric to Adult Health Care Providers: Ongoing Challenges and Opportunities for Young Persons with Diabetes.

Garvey K, Laffel L.

Endocr Dev. 2018;33:68-81. doi: 10.1159/000487866. Epub 2018 Jun 8.

PMID:
29886494
3.

Mobile Momentary Assessment and Biobehavioral Feedback for Adolescents with Type 1 Diabetes: Feasibility and Engagement Patterns.

Mulvaney SA, Vaala S, Hood KK, Lybarger C, Carroll R, Williams L, Schmidt DC, Johnson K, Dietrich MS, Laffel L.

Diabetes Technol Ther. 2018 Jun 8. doi: 10.1089/dia.2018.0064. [Epub ahead of print]

PMID:
29882677
4.

Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with Type 1 diabetes.

Teló GH, Dougher CE, Volkening LK, Katz ML, Laffel LM.

Diabet Med. 2018 Jun 1. doi: 10.1111/dme.13699. [Epub ahead of print]

PMID:
29855077
5.

Lost in transition: finding a path forward for young adults with Type 1 diabetes.

Laffel L.

Diabet Med. 2018 May 23. doi: 10.1111/dme.13684. [Epub ahead of print]

PMID:
29790218
6.

Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with Type 1 Diabetes.

McGill DE, Volkening LK, Butler DA, Harrington KR, Katz ML, Laffel LM.

Diabetes Technol Ther. 2018 May 4. doi: 10.1089/dia.2018.0037. [Epub ahead of print]

PMID:
29727245
7.

Pharmacokinetic and pharmacodynamic profile of the sodium-glucose co-transporter-2 inhibitor empagliflozin in young people with Type 2 diabetes: a randomized trial.

Laffel LMB, Tamborlane WV, Yver A, Simons G, Wu J, Nock V, Hobson D, Hughan KS, Kaspers S, Marquard J.

Diabet Med. 2018 Apr 14. doi: 10.1111/dme.13629. [Epub ahead of print]

PMID:
29655290
8.

Automated Insulin Delivery Systems: Hopes and Expectations of Family Members.

Garza KP, Jedraszko A, Weil LEG, Naranjo D, Barnard KD, Laffel LMB, Hood KK, Weissberg-Benchell J.

Diabetes Technol Ther. 2018 Mar;20(3):222-228. doi: 10.1089/dia.2017.0301.

PMID:
29565721
9.

Comparison of Surgical and Medical Therapy for Type 2 Diabetes in Severely Obese Adolescents.

Inge TH, Laffel LM, Jenkins TM, Marcus MD, Leibel NI, Brandt ML, Haymond M, Urbina EM, Dolan LM, Zeitler PS; Teen–Longitudinal Assessment of Bariatric Surgery (Teen-LABS) and Treatment Options of Type 2 Diabetes in Adolescents and Youth (TODAY) Consortia.

JAMA Pediatr. 2018 May 1;172(5):452-460. doi: 10.1001/jamapediatrics.2017.5763.

PMID:
29532078
10.

Barriers and strategies for oral medication adherence among children and adolescents with Type 2 diabetes.

Venditti EM, Tan K, Chang N, Laffel L, McGinley G, Miranda N, Tryggestad JB, Walders-Abramson N, Yasuda P, Delahanty L; TODAY Study Group.

Diabetes Res Clin Pract. 2018 May;139:24-31. doi: 10.1016/j.diabres.2018.02.001. Epub 2018 Feb 8.

PMID:
29427697
11.

Lipid Profiles, Inflammatory Markers, and Insulin Therapy in Youth with Type 2 Diabetes.

Levitt Katz LE, Bacha F, Gidding SS, Weinstock RS, El Ghormli L, Libman I, Nadeau KJ, Porter K, Marcovina S; TODAY Study Group.

J Pediatr. 2018 May;196:208-216.e2. doi: 10.1016/j.jpeds.2017.12.052. Epub 2018 Feb 2.

PMID:
29398050
12.

Management of Hypertension and High Low-Density Lipoprotein in Pediatric Type 1 Diabetes.

Katz ML, Guo Z, Laffel LM.

J Pediatr. 2018 Jun;197:140-146.e12. doi: 10.1016/j.jpeds.2017.11.059. Epub 2018 Feb 1.

PMID:
29395184
13.

Disordered Eating Behaviors Are Not Increased by an Intervention to Improve Diet Quality but Are Associated With Poorer Glycemic Control Among Youth With Type 1 Diabetes.

Eisenberg Colman MH, Quick VM, Lipsky LM, Dempster KW, Liu A, Laffel LMB, Mehta SN, Nansel TR.

Diabetes Care. 2018 Apr;41(4):869-875. doi: 10.2337/dc17-0090. Epub 2018 Jan 25.

PMID:
29371234
14.

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes.

Laffel LM, Aleppo G, Buckingham BA, Forlenza GP, Rasbach LE, Tsalikian E, Weinzimer SA, Harris DR.

J Endocr Soc. 2017 Nov 20;1(12):1461-1476. doi: 10.1210/js.2017-00389. eCollection 2017 Dec 1.

15.

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes.

Aleppo G, Laffel LM, Ahmann AJ, Hirsch IB, Kruger DF, Peters A, Weinstock RS, Harris DR.

J Endocr Soc. 2017 Nov 20;1(12):1445-1460. doi: 10.1210/js.2017-00388. eCollection 2017 Dec 1.

16.

Erratum. Factors Associated With Diabetes-Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study. Diabetes Care 2017;40:1002-1009.

Anderson BJ, Laffel LM, Domenger C, Danne T, Phillip M, Mazza C, Hanas R, Waldron S, Beck RW, Calvi-Gries F, Mathieu C.

Diabetes Care. 2018 Mar;41(3):640. doi: 10.2337/dc18-er03. Epub 2018 Jan 10. No abstract available.

17.

Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study.

Gidding SS, Bacha F, Bjornstad P, Levitt Katz LE, Levitsky LL, Lynch J, Tryggestad JB, Weinstock RS, El Ghormli L, Lima JAC; TODAY Study Group.

J Pediatr. 2018 Jan;192:86-92.e5. doi: 10.1016/j.jpeds.2017.09.012.

18.

Depressive Symptoms at Critical Times in Youth With Type 1 Diabetes: Following Type 1 Diabetes Diagnosis and Insulin Pump Initiation.

McGill DE, Volkening LK, Pober DM, Muir AB, Young-Hyman DL, Laffel LM.

J Adolesc Health. 2018 Feb;62(2):219-225. doi: 10.1016/j.jadohealth.2017.09.017. Epub 2017 Dec 6.

PMID:
29212599
19.

Randomized, double-blind, placebo-controlled dose-finding study of the dipeptidyl peptidase-4 inhibitor linagliptin in pediatric patients with type 2 diabetes.

Tamborlane WV, Laffel LM, Weill J, Gordat M, Neubacher D, Retlich S, Hettema W, Hoesl CE, Kaspers S, Marquard J.

Pediatr Diabetes. 2018 Jun;19(4):640-648. doi: 10.1111/pedi.12616. Epub 2017 Nov 24.

PMID:
29171139
20.

International Consensus on Use of Continuous Glucose Monitoring.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M.

Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600. Review.

PMID:
29162583

Supplemental Content

Loading ...
Support Center